NEW YORK (GenomeWeb News) – Forma Therapeutics today said that it will collaborate with Novartis on screening drug candidates for oncology applications.

The Cambridge, Mass.-based firm said that it would utilize its cell-based screening platform to identify inhibitors for undisclosed protein-protein interaction targets. Financial and other terms of the alliance were not disclosed.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

In PLOS this week: grey wolf population genomics, mutations associated with lung adenocarcinoma survival, and more.

An opinion piece at Bloomberg discusses China's stance on genomic research.

Genetic ancestry testing can affect a person's sense of identity, the New York Times Magazine writes.

Nebula Genomics is launching its genome sequencing service for free for people who provide certain information about themselves, the Boston Globe reports.